The slip
PARKINSON RECEIPTno. 12490
28 Oct 2026, 01:25 UTCdopamine neurons, braak
predictionARHGAP18 in dopamine neurons tracks Braak Lewy-body stage
registered0d0e03476ad4775a
discovery+0.30 p=0.430 n=9
replication-0.41 p=0.272 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.30, p 0.430)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTf90a671cf3a1e68dc2c39951…
follows 05d7986a8bdd…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12490: ARHGAP18 in dopamine neurons, braak
- power
- full sample -0.09 (p 0.728, n 18), 95% CI -0.53 to +0.40. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.14 (p 0.567, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.20 (p 0.418, n 18). could be the mix.
- skeptic
- leave-one-out range -0.21 to +0.03, sign flips 2; without severely affected donors -0.09 (p 0.728, n 18). fragile.
- cell type
- strongest in microglia: +0.65 (p 0.0033, n 18) vs -0.09 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ARHGAP18 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ARHGAP18 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.28 p 0.328 (needs p < 1.8e-4)